Companies /Healthcare

Heron Therapeutics Inc

NASDAQ: HRTX Biotechnology
$0.29
▲ $0.01 (+4.64%) today
Markets closed · 1:45am ET

HRTX at a Glance

Valuation
Market cap
$53.2M
Profitability
Revenue (TTM)
$151.2M
Profit margin
-22.5%
EPS (TTM)
$-0.18
Price
52-week range
$0 – $2
Street target
$7.00
Earnings
Next report
Nov 9, 2026

Headquartered in Cary, NC Fiscal year ends December NASDAQ: HRTX herontx.com

About Heron Therapeutics

Heron Therapeutics is a commercial-stage biotechnology company focused on developing and commercializing therapeutic innovations for acute care and oncology patients. The company markets four products: ZYNRELEF, an extended-release dual-acting local anesthetic for postoperative pain management; APONVIE, an IV-administered NK1 receptor antagonist for prevention of postoperative nausea and vomiting; CINVANTI, an IV formulation of aprepitant for prevention of chemotherapy-induced nausea and vomiting; and SUSTOL, an extended-release injectable 5-HT3 receptor antagonist for CINV prevention. The company's revenue is split between an Acute Care franchise (ZYNRELEF and APONVIE) and an Oncology Supportive Care franchise (CINVANTI and SUSTOL). Heron utilizes proprietary Biochronomer drug delivery technology. The company is currently considering strategic alternatives and faces uncertainty around potential generic competition for CINVANTI following a recent patent court ruling. Updated

Latest Activity

Earnings on deck — Nov 9–13
601 companies248 before open353 after close

601 companies report next week, and Monday alone front-loads the power trade: Constellation Energy, NRG and Fervo Energy all deliver before the open, alongside KKR, Barrick Mining and monday.com. Data center electricity demand gets its clearest read of the quarter.

  • CEGConstellation Energy CorporationMon Nov 9Before open
  • MNDYmonday.com Ltd.Mon Nov 9Before open
  • NRGNRG Energy, Inc.Mon Nov 9Before open
  • SBETSharplink, Inc.Mon Nov 9Before open
  • VRTSVirtus Investment Partners, Inc.Mon Nov 9Before open
  • BBarrick Mining CorporationMon Nov 9Before open
  • CEVACeva, Inc.Mon Nov 9Before open
  • CGENCompugen Ltd.Mon Nov 9Before open
  • IONSIonis Pharmaceuticals, Inc.Mon Nov 9Before open
  • UNITUniti Group Inc.Mon Nov 9Before open
  • FRVOFervo Energy CompanyMon Nov 9Before open
  • HRTXHeron Therapeutics, Inc.Mon Nov 9Before open
  • KGSKodiak Gas Services, Inc. Mon Nov 9Before open
  • KKRKKR & Co. Inc.Mon Nov 9Before open
  • KSPIJoint Stock Company Kaspi.kzMon Nov 9Before open
Read more

HRTX Coverage

Frequently Asked Questions

What does Heron Therapeutics do?

Heron Therapeutics is a commercial-stage biotechnology company focused on developing and commercializing therapeutic innovations for acute care and oncology patients.

What is the HRTX stock price target?

The Wall Street consensus 12-month price target for HRTX is $7.00.